Prediction of absolute risk of acute graft-versus-host disease following hematopoietic cell transplantation

Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually

(2016) J R Passweg et al.   BONE MARROW TRANSPLANTATION

Super Learner Analysis of Electronic Adherence Data Improves Viral Prediction and May Provide Strategies for Selective HIV RNA Monitoring

(2015) Maya L. Petersen et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Mortality prediction in intensive care units with the Super ICU Learner Algorithm (SICULA): a population-based study

(2015) Romain Pirracchio et al.   Lancet Respiratory Medicine

Prognostic Biomarkers for Acute Graft-versus-Host Disease Risk after Cyclophosphamide–Fludarabine Nonmyeloablative Allotransplantation

(2014) Robert P. Nelson et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation

(2014) Doris M. Ponce et al.   BLOOD

Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality

(2014) M. L. Sorror et al.   BLOOD

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation

(2014) J. Pidala et al.   BLOOD

How well can post-traumatic stress disorder be predicted from pre-trauma risk factors? An exploratory study in the WHO World Mental Health Surveys

(2014) Ronald C. Kessler et al.   World Psychiatry

Mortality Risk Score Prediction in an Elderly Population Using Machine Learning

(2013) Sherri Rose   AMERICAN JOURNAL OF EPIDEMIOLOGY

Assessing the Value of Risk Predictions by Using Risk Stratification Tables

(2013) Holly Janes et al.   ANNALS OF INTERNAL MEDICINE

Significant Improvement in Survival After Allogeneic Hematopoietic Cell Transplantation During a Period of Significantly Increased Use, Older Recipient Age, and Use of Unrelated Donors

(2013) Theresa Hahn et al.   JOURNAL OF CLINICAL ONCOLOGY

ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and Death

(2013) Mark T. Vander Lugt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study

(2012) J. E. Levine et al.   BLOOD

Biomarkers for acute GVHD: can we predict the unpredictable?

(2012) Y-B Chen et al.   BONE MARROW TRANSPLANTATION

Advances in predicting acute GVHD

(2012) Andrew C. Harris et al.   BRITISH JOURNAL OF HAEMATOLOGY

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

(2011) M. E. D. Flowers et al.   BLOOD

Risk factors for acute GVHD and survival after hematopoietic cell transplantation

(2011) M. Jagasia et al.   BLOOD

BART: Bayesian additive regression trees

(2010) Hugh A. Chipman et al.   Annals of Applied Statistics

Genetic Variations of Interleukin-23R (1143A>G) and BPI (A645G), but Not of NOD2, Are Associated with Acute Graft-versus-Host Disease after Allogeneic Transplantation

(2010) Martin Wermke et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Pathogenesis and Management of Graft-versus-Host Disease

(2010) Sung W. Choi et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation

(2010) Ted A. Gooley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Graft-versus-host disease

(2009) James LM Ferrara et al.   LANCET

Chronic Graft-versus-Host Disease—Implementation of the National Institutes of Health Consensus Criteria for Clinical Trials

(2008) Linda M. Griffith et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

A biomarker panel for acute graft-versus-host disease

(2008) S. Paczesny et al.   BLOOD